These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29935119)

  • 1. Kappa opioid receptor binding in major depression: A pilot study.
    Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
    Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
    Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
    Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.
    Talbot PS; Narendran R; Butelman ER; Huang Y; Ngo K; Slifstein M; Martinez D; Laruelle M; Hwang DR
    J Nucl Med; 2005 Mar; 46(3):484-94. PubMed ID: 15750163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
    Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
    J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
    Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
    ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography.
    Smart K; Yttredahl A; Oquendo MA; Mann JJ; Hillmer AT; Carson RE; Miller JM
    Transl Psychiatry; 2021 Nov; 11(1):602. PubMed ID: 34839360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.
    Pietrzak RH; Naganawa M; Huang Y; Corsi-Travali S; Zheng MQ; Stein MB; Henry S; Lim K; Ropchan J; Lin SF; Carson RE; Neumeister A
    JAMA Psychiatry; 2014 Nov; 71(11):1262-1271. PubMed ID: 25229257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.
    Zanderigo F; Pantazatos S; Rubin-Falcone H; Ogden RT; Chhetry BT; Sullivan G; Oquendo M; Miller JM; Mann JJ
    Brain Struct Funct; 2018 Jul; 223(6):2609-2625. PubMed ID: 29550938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers.
    Matuskey D; Dias M; Naganawa M; Pittman B; Henry S; Li S; Gao H; Ropchan J; Nabulsi N; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1714-1719. PubMed ID: 30928993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Kappa Opioid Receptor Agonist as Improved PET Radiotracer: Development and in Vivo Evaluation.
    Li S; Zheng MQ; Naganawa M; Gao H; Pracitto R; Shirali A; Lin SF; Teng JK; Ropchan J; Huang Y
    Mol Pharm; 2019 Apr; 16(4):1523-1531. PubMed ID: 30726092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the in vivo selectivity of a new κ-opioid receptor antagonist PET tracer 11C-LY2795050 in the rhesus monkey.
    Kim SJ; Zheng MQ; Nabulsi N; Labaree D; Ropchan J; Najafzadeh S; Carson RE; Huang Y; Morris ED
    J Nucl Med; 2013 Sep; 54(9):1668-74. PubMed ID: 23918735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
    Placzek MS
    Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging reveals lower kappa opioid receptor availability in alcoholics but no effect of age.
    Vijay A; Cavallo D; Goldberg A; de Laat B; Nabulsi N; Huang Y; Krishnan-Sarin S; Morris ED
    Neuropsychopharmacology; 2018 Dec; 43(13):2539-2547. PubMed ID: 30188515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.
    Li S; Zheng MQ; Naganawa M; Kim S; Gao H; Kapinos M; Labaree D; Huang Y
    J Nucl Med; 2019 Jul; 60(7):1023-1030. PubMed ID: 30630942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques.
    Schoultz BW; Hjornevik T; Willoch F; Marton J; Noda A; Murakami Y; Miyoshi S; Nishimura S; Arstad E; Drzezga A; Matsunari I; Henriksen G
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1174-80. PubMed ID: 20157708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.